Skip to main content

Policy Notices

COVID-19 Emergency Policies and Data Collection

Implemented

  • 1.4.F: Updates to Candidate Data during 2020 COVID-19 Emergency
  • 3.7.D: Applications for Modification of Kidney Waiting Time during 2020 COVID-19 Emergency
  • 18.1: Data Submission Requirements
  • 18.2: Timely Collection of Data
  • 18.5.A: Reporting Requirements after Living Kidney Donation
  • 18.5.B: Reporting Requirements after Living Liver Donation

Pending Implementation

Target: January 2021

  • Policy 2.2: Required Deceased Donor Information

Actions Pending Implementation

Target implementation date: February 2021

Pancreas Removal of DSA
12/2019 Board action

Kidney Removal of DSA
12/2019 Board action

Addressing Medically Urgent Candidates in New Kidney Allocation Policy
6/2020 Board action

Distribution of Kidneys and Pancreata from Alaska
6/2020 Board action

Modifications to Released Kidney and Pancreas Allocation
6/2020 Board action

Target implementation date: February 9, 2021

Guidance Addressing the Use of Pediatric Heart Exceptions
12/2020 Board action

Guidance and Policy Addressing Adult Heart Allocation
12/2020 Board action

  • Guidance for Adult Heart Exceptions for Status 2 Candidates Experiencing Cardiogenic Shock

Target implementation date: March 2021

Align OPTN Policy with US PHS Guideline 2020 
Split implementation. Actions targeted for June 2021 below

12/2020 Board Action

  • 1.2: Definitions
  • 2.2: OPO Responsibilities
  • 2.4: Deceased Donor Medical and Behavioral History
  • 2.5: Hemodilution Assessment
  • 2.7.A: Exceptions to HIV Screening Requirement
  • 2.9: Required Deceased Donor Infectious Disease Testing
  • 13.11:  Receiving and Accepting KPD Match Offers
  • 14.1.A: Living Donor Psychosocial Evaluation Requirements
  • 14.4.A: Living Donor Medical Evaluation Requirements
  • 14.9.B: Psychosocial and Medical Evaluation Requirements for Domino and Non-Domino Therapeutic Donors
  • 15.2:  Potential Candidate Screening Requirements
  • 15.3.B: Donors with  Risk Identified Pre-Transplant
  • 15.3.C: Recipients of Organs from Donors with   Increased Risk of Disease Transmission
  • 16.3.D: internal labeling of Extra Vessels

Guidance and Policy Addressing Adult Heart Allocation
12/2020 Board action

  • Policy 6.1.A.ii: Non-dischargeable, surgically implanted, non-endovascular biventricular support device
  • Policy 6.1.C.vi: Mechanical Circulatory Support Devise (MCSD) with Device Infection
  • Policy 6.1.D.ii: Inotropes without Hemodynamic Monitoring

Modify Data Submission Policies

12/2019 Board action 

Expedited Placement of Livers
12/2019 Board action

Target implementation date: June 2021

Align OPTN Policy with US PHS Guideline 2020
12/2020 Board Action

  • Policy 14.8.B: Living Donor Specimen Collection and Storage
  • Policy 14.3: Informed Consent Requirements

Further Enhancements to the National Liver Review Board
12/20 Board action

Combined Policy Notice for VCA Membership Requirements (2020)
6/2015, 6/2016, 6/2018 Board action

VCA Membership Bylaws Requirements
6/2015 Board action

VCA - List Covered Body Parts - 1 of 2
6/2016 Board action

  • Policy 1.2: Definitions
  • Bylaws Appendix D: Membership Requirements for Transplant Hospitals and Transplant Programs; Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs; and Appendix M: Definitions

Align VCA Program Membership Requirements with Other Programs
6/2018 Board action

National Heart Review Board for Pediatrics
6/2020 Board action

Human Leukocyte Antigen (HLA) Equivalency Tables Update 2020
6/2020 Board action

Changes to Islet Bylaws
12/2018 Board action

Target implementation date: July 2021

Updated Cohort for Calculation of the LAS
12/2020 Board action

Target implementation date: June 2022

OPTN Data Collection Changes: Update to VCA Transplant Outcomes Data Collection
6/2020 Board action

Programming VCA Allocation in UNet
12/2020 Board action

Modify Data Collection on Living VCA Donors (pending OMB approval)
12/2020 Board action

Implemented

2020

Establish Pediatric Training and Experience
12/2015 Board actions

Effective Date: December 7, 2020

Revise Pediatric Emergency Membership Exception Pathway
12/2017 Board action

Effective date: December 7, 2020

Incorporating COVID-19 Related Organ Failure In Candidate Listings 
10/2020 Board action

Effective date: October 28, 2020

Enhancements to the National Liver Review Board
6/2020 Board action

  • Policies 9.4.A: MELD or PELD Score Exception Requests and 9.4.D: Calculation of Median MELD or PELD at Transplant: Effective August 4, 2020
  • Operational Guidelines: Effective August 4, 2020
  • Operational Guidance: Effective August 4, 2020
  • Policies 9.4.C: MELD or PELD Score Exception Extensions and 9.5.I.vii: Extensions of HCC Exceptions: Effective September 10, 2020

Guidance and Policy Modifications Addressing Blood Type Determination
6/2020 Board action

  • Guidance: Effective June 8, 2020
  • Policy: Effective September 1, 2020

Modify the Conflicts of Interests Bylaws
6/2020 Board action

Effective date: July 1, 2020

Creation of OPTN Heart and Lung Committees
3/2020 Board action

Effective date: July 1, 2020

Modify Lung TRF to Improve Post Transplant Lung Function Data
6/2018 Board action

Effective date: June 30, 2020

Eliminate the Use of Regions in VCA Distribution
6/2019 Board action

Effective date: June 18, 2020

Modify HOPE Act Variance to Include Other Organs
6/2019 Board action

Effective date: May 21, 2020

COVID-19 Emergency Policy Package (PDF - 765 K)
04/2020 Executive Committee action

Effective date: April 3, 2020

Clarifications on Reporting Maintenance Dialysis
6/2019 Board action

Effective date: April 1, 2020

Updates to Candidate Data During 2020 COVID-19 Emergency
03/2020 Executive Committee action

Effective date: March 17, 2020

Variances Removal Policy Notice
12/2019 Board action

Effective date: March 1, 2020

Clarification of Pre-Existing Liver Disease
12/2019 Board action

Effective March 1, 2020

Addressing HLA Typing Errors
12/2018 Board action

Effective February 27, 2020

Access for Urgent Liver Candidates in Hawaii & Puerto Rico
01/2020 Executive Committee action

Effective February 18, 2020

Liver and Intestine Distribution Using Distance from Donor Hospital
12/2018 Board action

Effective February 4, 2020

Reduce Reporting Burdens and Clarify Policies on Extra Vessels
6/2018 Board action 

Effective January 29, 2020

  • Table 16.1: Required information on internal labels for extra vessels, number 7 (donor infectious disease results)

Update Transplant Hospital Definition
12/2016 Board action

Effective January 13, 2020

Eliminate the Use of DSAs in Thoracic Organ Distribution
6/2019 Board action

Effective January 9, 2020

2019

Adding DR Antigens and Equivalences
12/2019 Board Action

Effective December 4, 2019

Hope Act Policy and Mini Brief
12/2019 Board action

Effective December 3, 2019

Modify Appointment Process for the Histocompatibility Vice Chair
12/2019 Board Action

Effective December 3, 2019

Aligning Units of Distribution in Closed Variance for Split Liver Transplantation
12/2019 Board Action

Effective December 3, 2019

Split Liver Variance
6/2019 Board action

Effective December 3, 2019

Revising Priority Points in Kidney Paired Donation Program
12/2015 Board action; 10/2019 Executive Committee action

Effective October 24, 2019

Improving Dual Kidney Allocation
12/2017 Board action

Effective September 2019

Improving en Bloc Kidney Allocation
12/2017 Board action

Effective September 2019

Changes to Waiting Time Criteria for Kidney-Pancreas Candidates
6/2018 Board action

Effective 7/11/2019

Guidance on Effective Practices in Organ Distribution 
6/2019 Board action

Effective 6/10/2019

Ethical Iimplications of Multi-Organ Transplants White Paper
6/2019 Board action

Effective 6/10/2019

Revised National Liver Review Board Policies
12/2018 Board action

Effective 5/14/2019

National Liver Review Board
6/2017 Board action

Effective 5/14/2019

Histocompatibility Bylaws Rewrite: General Supervisor
6/2015 Board action 

Effective 3/1/2018

Pancreas Program Functional Inactivity
12/2018 Board action

Effective 4/8/2019

Addressing HLA Typing Errors
12/2018 Board action

Effective 3/1/2019

  • Policy 2.2 (OPO responsibilities)
  • Bylaws C.2.D (OPO affiliation)

Amend CPRA Calculator
1/2019 Executive Committee action

Effective 1/17/2019

2018

Change to Hospital-Based OPO Voting Privileges
12/2018 Board action

Effective 12/4/2018

Frameworks for Organ Distribution
12/2018 Board action

Effective 12/4/2018

Pediatric Transition and Transfer Guidance
12/2018 Board action

Effective 12/3/2018

Intestine Membership Bylaws Requirements
6/2015 Board action

Effective 11/20/2018

Modify Adult Heart Allocation
12/2016 Board action

Effective 10/18/2018

Clarification of Adult Heart Allocation
8/2017 Executive Committee action

Effective 10/18/2018

Review Board Guidance on HCM and RCM Exceptions
6/2018 Board action

Effective 10/18/2018

Modifications to the Distribution of Deceased Donor Lungs
6/2018 Board action

Effective 10/18/2018 (Policy 6.6.F)

Effective 6/12/2018 (Policies 1.2, 10.2.A, 10.4)

Clarify Informed Consent Policies for Transmittable Diseases
6/2018 Board action

Effective 9/1/2018

Reduce Reporting Burdens and Clarify Policies on Extra Vessels
6/2018 Board action 

Effective 9/1/2018 (except table 16.1)

VCA - List Covered Body Parts (2 0f 2)
6/2016 Board action

  • Bylaws Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs: Effective September 1, 2018
  • Policy 1.2: Definitions: Target implementation date: December 2021
  • Bylaws Appendix D: Membership Requirements for Transplant Hospitals and Transplant Programs; Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs; and Appendix M: Definitions: Target implementation date: December 2021

Effective date: 9/1/2018

Improving the Efficiency of Organ Allocation
12/2017 Board action

Effective 3/1/2018 (Policies 2.2, 2.11 and 2.12)

Effective 5/2/2018 (Policies 1.2 and 5.6.B)

Effective 6/12/2018 (Policies 2.11.A and 2.11.D)

Effective 6/13/2018 (Policy 5.6.C)

Revising OPTN Bylaws Appendix L
6/2018 Board action

Effective 6/12/2018

Retrospective Review of Clerical Policy Changes 
6/2018 Executive Committee action

Effective 6/12/2018

Approved Transplant Fellowship Training Programs Bylaws 
12/2017 Board action

Effective 3/1/2018

Definition of Pancreas Graft Failure
6/2015 Board action

Effective 2/28/2018

Modification to HCC Extension Criteria
Effective 2/5/2018

2017

HCC Auto Approval Criteria Changes 
12/2016 Board action; 12/2017 Executive Committee action

Effective 12/12/2017

Lung Allocation Policy Modification
11/2017 Executive Committee action

Effective 11/24/2017

Standardize Organ Coding and Tracking System 
2/2017 Executive Committee action

Effective 11/01/2017

Improve the Categorization of Living Donor Events (PDF - 135 K)
9/2017 executive committee action

Effective 10/18/2017

Add DQA-1 Equivalences Table 
6/2016 Board action; 6/2017 Executive Committee action

Effective 9/12/2017

Update HLA Equivalency Tables 
12/2015 Board action; 4/2017 Executive Committee action

 Effective 9/12/2017

Personnel Procurement Requirements 
12/2015 Board action

Effective 9/1/2017

Foreign Equivalent in Bylaws 
12/2015 Board action

Effective 9/1/2017

Bylaws Rewrite 
6/2017 Board action

Effective 9/1/2017

Primary Kidney Transplant Physician Update 
12/2016 Board action

Effective 9/1/2017

Clarification to Apply Kidney Minimum Acceptance Criteria to Highly Sensitized Candidates 
7/2017 Executive Committee action

Effective 9/1/2017

Simultaneous Liver-Kidney Allocation 
6/2016 Board action

Effective 8/10/2017

Kidney: KAS Clarifications (part) 
6/2016 Board action

Effective 6/29/2017

Retrospective Review of Clerical Changes to Policies  
6/2017 Executive committee action

Effective 6/29/2017

Informed Consent Changes - Potential Living Donors 
12/2016 Board action

Effective 6/1/2017

Improving Post-Transplant Communication (part) 
6/2016 Board action; Required toxoplasmosis testing of all donors

Effective 4/6/2017

Pediatric Lung Allocation Changes 
12/2015 Board action

Effective 3/30/2017

All Other KPD Guidelines to Policy (part) 
6/2015 Board action

 Effective 3/30/2017

Post-Implementation ABO Policy Changes
12/2016 Board action

Effective 3/1/2017

Primary Transplant Surgeon Changes
12/2016 Board action

Effective 3/1/2017

Primary Transplant Physician Subspecialty Changes 
12/2016 Board action

Effective 3/1/2017

Remove Donor Location from Required Procurement Log
12/2016 Board action

Effective 3/1/2017

Changes to Imminent and Eligible Definitions
12/2016 Board action

 Effective 1/1/2017

2016

Retrospective Review of Clerical Changes to Policies
12/2016 Executive committee action

Effective 11/10/2016

Registration Fee
6/2016 Board action

Effective 10/1/2016

DTAC Policy Clarification
6/2016 Executive Committee action

Effective 9/1/2016

OSC Policy Clarification
8/2016 Executive Committee action

Effective 9/1/2016

HOPE Act
6/2016 Board action

Effective 9/1/2016

Improving Post-Transplant Communication (part) 
6/2016 Board action

Effective 9/1/2016

Kidney: KAS Clarifications (part) 
6/2016 Board action

Effective 9/1/2016

Regional Councillor Vacancy
6/2016 Board action

Effective 9/1/2017

Living Donor Candidate Registration 
4/2016 Executive Committee action

 Effective 4/14/2016

Retrospective Review of Clerical Changes to Policies 
12/2016 Executive committee action

Effective 4/14/2016

2015

KPD Informed Consent
6/2015 Board action

Effective 12/1/2015

Other Actions

12/2015 Board Actions

11/2015 Executive Committee Actions

OSC - ABO Policy Updates
6/2015 Board action

KPD Updates
6/2015 Board action

Pancreas Updates
6/2015 Board action

POC Updates 
6/2015 Board action

OPO Committee Updates
6/2015 Board action

VCA Committee Updates
6/2015 Board action

11/2014 Board Actions

Clerical Changes to KP Transition Plan Policy
9/2014 Executive Committee action

Register Living Donor Candidates Before Transplant
8/2014 Executive Committee action

6/2014 Board Actions - 1 

6/2014 Board Actions - 2 

3/2014 Policy Corrections 

Clarification for OPOs on PHS Guideline Documentation 
1/2014 action

11/2013 Board Actions 

8/2013 Executive Committee Actions 

6/2013 board meeting Actions 

Discretionary Listing of Pediatric Lung Transplant Candidates 
6/2013 action

5/2013 Executive Committee Actions 

11/2012 Board Actions 

Liver Committee updates 
6/2012 Board actions

Thoracic Committee Updates 
6/2012 Board actions

Changes to Policy, Bylaws and Kidney Paired Donation Guidelines
5/2012 actions

New Post Transplant Requirements for Liver Programs 
4/2012 actions

Looking for something else? Contact us at unoscommunications@unos.org or (804) 782-4800. We maintain an archive of historical OPTN documents.

Requires Adobe Acrobat Reader [Exit Disclaimer]